12 insiders reported 111 Form 4 transactions for Beta Bionics, Inc. (BBNX) over the past 18 months (most recent 2026-07-02). Recent activity: Feider Stephen (Chief Financial Officer) Sell 5,104 shares, Feider Stephen (Chief Financial Officer) Buy 4,896 shares, Feider Stephen (Chief Financial Officer) Sell 4,896 shares, Feider Stephen (Chief Financial Officer) Buy 5,104 shares, Feider Stephen (Chief Financial Officer) Buy 4,982 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Feider Stephen | Chief Financial Officer | Sell | 5,104 | $87,006 |
| 2026-07-02 | Feider Stephen | Chief Financial Officer | Buy | 4,896 | $24,970 |
| 2026-07-02 | Feider Stephen | Chief Financial Officer | Sell | 4,896 | $83,381 |
| 2026-07-02 | Feider Stephen | Chief Financial Officer | Buy | 5,104 | $26,030 |
| 2026-06-30 | Feider Stephen | Chief Financial Officer | Buy | 4,982 | $25,408 |
| 2026-06-30 | Feider Stephen | Chief Financial Officer | Sell | 5,104 | $87,006 |
| 2026-06-30 | Feider Stephen | Chief Financial Officer | Buy | 4,896 | $24,970 |
| 2026-06-30 | Feider Stephen | Chief Financial Officer | Sell | 4,896 | $83,381 |
| 2026-06-25 | Jones Christy | Director | Sell | 1,406 | $21,090 |
| 2026-06-25 | Hopman Mark | Chief Commercial Officer | Sell | 1,258 | $18,880 |
| 2026-06-05 | Hopman Mark | Chief Commercial Officer | Sell | 275 | $3,385 |
| 2026-06-05 | Jones Christy | Director | Sell | 2,811 | $39,354 |
| 2026-06-03 | Feider Stephen | Chief Financial Officer | Sell | 6,676 | $84,165 |
| 2026-06-03 | Mensinger Mike | Chief Product Officer | Sell | 4,378 | $55,194 |
| 2026-06-03 | Hopman Mark | Chief Commercial Officer | Sell | 5,329 | $67,183 |
| 2026-06-03 | Saint Sean | President & CEO | Sell | 16,872 | $212,707 |
| 2026-06-03 | Russell Steven Jon | Chief Medical Officer | Sell | 4,222 | $53,227 |
| 2026-03-16 | Hopman Mark | Chief Commercial Officer | Sell | 856 | $25,115 |
| 2026-03-16 | Hopman Mark | Chief Commercial Officer | Sell | 2,061 | $63,190 |
| 2026-03-16 | Russell Steven Jon | Chief Medical Officer | Sell | 1,025 | $30,074 |
| 2026-03-05 | Hopman Mark | Chief Commercial Officer | Sell | 353 | $4,084 |
| 2026-03-03 | Russell Steven Jon | Chief Medical Officer | Buy | 109,105 | $0 |
| 2026-03-03 | Russell Steven Jon | Chief Medical Officer | Sell | 1,026 | $12,681 |
| 2026-03-03 | Mensinger Mike | Chief Product Officer | Buy | 109,105 | $0 |
| 2026-03-03 | Mensinger Mike | Chief Product Officer | Sell | 1,064 | $13,151 |
Source: SEC Form 4 filings · as of 2026-07-02